Cerevel Therapeutics
CERE
#2324
Rank
โ‚ฌ7.00 B
Marketcap
38,46ย โ‚ฌ
Share price
0.00%
Change (1 day)
102.57%
Change (1 year)

EPS for Cerevel Therapeutics (CERE)

EPS in 2024 (TTM): -2,45ย โ‚ฌ

According to Cerevel Therapeutics's latest financial reports the company's current EPS (TTM) is -2,26ย โ‚ฌ. In 2022 the company made an earnings per share (EPS) of -1,98ย โ‚ฌ a decrease over its 2021 EPS that were of -1,41ย โ‚ฌ.

EPS history for Cerevel Therapeutics from 2020 to 2024

Annual EPS

Year EPS Change
2024 (TTM)-2,45ย โ‚ฌ
2022-1,98ย โ‚ฌ40.61%
2021-1,41ย โ‚ฌ36.84%
2020-1,03ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Archer Daniels Midland (ADM)
ADM
1,92ย โ‚ฌ-185.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Campbell's
CPB
1,58ย โ‚ฌ-170.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Dow
DOW
-3,16ย โ‚ฌ 39.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Dupont De Nemours
DD
-1,59ย โ‚ฌ-29.55%๐Ÿ‡บ๐Ÿ‡ธ USA